ArticleCancer medicine2023

Risk factors associated with overall survival in patients with multiple myeloma following carfilzomib treatment: A retrospective study from a large claims database in Japan.

Hiromi Hagiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.